Eli Lilly and Co (NYSE:LLY)

111.34
Delayed Data
As of Jun 26
 -4.02 / -3.48%
Today’s Change
84.64
Today|||52-Week Range
132.13
-3.78%
Year-to-Date
Axsome Initiates Phase III Study on Depression Candidate
Jun 25 / Zacks.comZAK - Paid Partner Content
Opinion: Medical Marijuana Is a Terrible Investment
Jun 20 / MotleyFool.comFOO - Paid Partner Content
The 10 Biggest Biotech Stocks
Jun 25 / MotleyFool.comFOO - Paid Partner Content
Lilly Declares Third-Quarter 2019 Dividend
Jun 19 / PR NewswirePRN - Paid Partner Content
Why These Innovative Biotech ETFs Soaring
Jun 24 / Zacks.comZAK - Paid Partner Content
Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio
Jun 18 / Zacks.comZAK - Paid Partner Content
3 Drugs Under FDA Review With Blockbuster Potential
Jun 20 / MotleyFool.comFOO - Paid Partner Content
Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients
Jun 18 / Zacks.comZAK - Paid Partner Content
Allergan Up As Analyst Statement Sparks Business Split Rumors
Jun 20 / Zacks.comZAK - Paid Partner Content
Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon
Jun 17 / MotleyFool.comFOO - Paid Partner Content

Today’s Trading

Previous close115.36
Today’s open114.81
Day’s range110.62 - 114.95
Volume4,677,503
Average volume (3 months)12,459,727
Market cap$112.1B
Data as of 3:59pm ET, 06/26/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+1.49%
Earnings growth (next 5 years)+9.17%
Revenue growth (last year)+7.36%
P/E ratio43.0
Price/Sales4.87
Price/Book12.42

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.34-0.78%
AZNAstraZeneca-0.43-1.04%
ABBVAbbVie+2.30+3.50%
GSKGlaxoSmithKline-0.50-1.23%
Data as of 4:02pm ET, 06/26/2019

Financials

Next reporting dateJuly 30, 2019
EPS forecast (this quarter)$1.44
Annual revenue (last year)$24.6B
Annual profit (last year)$3.2B
Net profit margin13.16%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP &
President-Manufacturing Operations
Myles Oneill
Corporate headquarters
Indianapolis, Indiana

Forecasts